Free Trial

The Allstate Co. (NYSE:ALL) Receives Consensus Rating of "Moderate Buy" from Brokerages

Allstate logo with Finance background

The Allstate Co. (NYSE:ALL - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the sixteen brokerages that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, twelve have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $214.19.

Several analysts have recently weighed in on ALL shares. UBS Group upped their price objective on Allstate from $216.00 to $225.00 and gave the company a "buy" rating in a report on Monday, November 4th. TD Cowen raised their price objective on shares of Allstate from $193.00 to $224.00 and gave the company a "buy" rating in a research report on Tuesday, September 3rd. Wells Fargo & Company boosted their target price on shares of Allstate from $175.00 to $186.00 and gave the stock an "equal weight" rating in a report on Tuesday, November 5th. Raymond James raised their target price on shares of Allstate from $205.00 to $220.00 and gave the stock a "strong-buy" rating in a report on Friday, October 4th. Finally, Keefe, Bruyette & Woods upped their price target on Allstate from $222.00 to $225.00 and gave the company an "outperform" rating in a report on Wednesday, November 6th.

Get Our Latest Analysis on Allstate

Allstate Price Performance

Shares of ALL stock traded down $0.13 during midday trading on Wednesday, reaching $196.47. 193,188 shares of the company were exchanged, compared to its average volume of 1,532,645. The company's 50 day moving average price is $190.50 and its two-hundred day moving average price is $177.22. The company has a market cap of $52.03 billion, a P/E ratio of 12.73, a PEG ratio of 1.76 and a beta of 0.48. Allstate has a 12 month low of $134.17 and a 12 month high of $201.00. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40.

Allstate (NYSE:ALL - Get Free Report) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion for the quarter, compared to analysts' expectations of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm's quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.81 earnings per share. On average, sell-side analysts expect that Allstate will post 16.01 earnings per share for the current year.

Allstate Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be given a dividend of $0.92 per share. The ex-dividend date is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 1.87%. Allstate's payout ratio is presently 23.83%.

Insider Activity

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 57.06 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.80% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Allstate

Hedge funds have recently modified their holdings of the stock. BDF Gestion acquired a new position in Allstate in the 2nd quarter worth about $3,051,000. OFI Invest Asset Management acquired a new position in Allstate in the second quarter worth approximately $476,000. Cetera Investment Advisers raised its position in Allstate by 351.6% during the first quarter. Cetera Investment Advisers now owns 65,221 shares of the insurance provider's stock valued at $11,284,000 after acquiring an additional 50,780 shares in the last quarter. Diversified Trust Co raised its position in Allstate by 505.3% during the second quarter. Diversified Trust Co now owns 7,923 shares of the insurance provider's stock valued at $1,265,000 after acquiring an additional 6,614 shares in the last quarter. Finally, Canada Pension Plan Investment Board lifted its stake in Allstate by 97.5% in the first quarter. Canada Pension Plan Investment Board now owns 271,464 shares of the insurance provider's stock valued at $46,966,000 after acquiring an additional 134,028 shares during the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.

Allstate Company Profile

(Get Free Report

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Recommended Stories

Analyst Recommendations for Allstate (NYSE:ALL)

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines